A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022
Clinical trial NCT05912296 · COMPLETED
Trial details
- NCT number
- NCT05912296
- Sponsor
- Suzhou Ribo Life Science Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-30
- Primary completion
- 2025-03-04
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.